MAPT and Alzheimer disease: In several cases, impairment of E3 ligases has been shown to also directly impact the degradation of Tau, Aβ, and APP, leading to the accumulation of toxic forms of these AD-associated proteins, further disrupting proteasome activity and promoting neurofibrillary tangles (137, 138).